Emerging strategies in BRCA-positive pancreatic cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/article/10.1007/s00432-018-2666-9/fulltext.html
Reference24 articles.
1. Beger C et al (2004) Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma. Clin Cancer Res 10(11):3780–3787. https://doi.org/10.1158/1078-0432.CCR-0992-3
2. Biankin AV, Maitra A (2015) Subtyping pancreatic cancer. Cancer Cell 28(4):411–413. https://doi.org/10.1016/j.ccell.2015.09.020
3. de Bono J et al (2017) ‘Phase I, dose-escalation, two-part trial of the PARP inhibitor Talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers.’, Cancer discovery. Am Assoc Cancer Res 7(6):620–629. https://doi.org/10.1158/2159-8290.CD-16-1250
4. Golan T et al (2014) Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers. Br J Cancer 111(6):1132–1138. https://doi.org/10.1038/bjc.2014.418
5. Golan T et al (2017) Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. Br J Cancer 116(6):697–702. https://doi.org/10.1038/bjc.2017.19
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Familial pancreatic cancer registry and surveillance study for the early detection of pancreatic cancer;Suizo;2024-08-30
2. Auger emitter in combination with Olaparib suppresses tumor growth via promoting antitumor immune responses in pancreatic cancer;Investigational New Drugs;2024-06-28
3. Management of Primary Pancreatic Cancer;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23
4. Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN);Pancreatology;2023-09
5. Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics—A Review;Digestive Diseases and Sciences;2023-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3